UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 9, 2006
Lifeline Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Colorado
|
|
000-30489
|
|
84-1097796 |
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
6400 South Fiddler’s Green Circle, Suite 1970, Englewood, CO 80111
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (720) 488-1711
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure
On February 9, 2006, Lifeline Therapeutics, Inc. issued a press release entitled “Lifeline
Therapeutics, Inc. Schedules Second Quarter Earnings Conference Call and Webcast.” The press
release is attached as Exhibit 99.1 hereto.
Item 9.01 Exhibits
99.1 Press Release, dated February 9, 2006, entitled “Lifeline Therapeutics, Inc. Schedules
Second Quarter Earnings Conference Call and Webcast.”
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.
Date: February 9, 2006
| |
|
|
|
|
| |
LIFELINE THERAPEUTICS, INC.
|
|
| |
By: |
/s/ Gerald J. Houston
|
|
| |
|
Gerald J. Houston |
|
| |
|
Chief Financial Officer |
|
| |